Melikian A A, O'Connor R, Prahalad A K, Hu P, Li H, Kagan M, Thompson S
Naylor Dana Institute, American Health Foundation, Valhalla, NY 10595, USA.
Carcinogenesis. 1999 Apr;20(4):719-26. doi: 10.1093/carcin/20.4.719.
To investigate how various levels of exposure affect the metabolic activation pathways of benzene in humans and to examine the relationship between urinary metabolites and other biological markers, we have developed a sensitive and specific liquid chromatographic-tandem mass spectrometric assay for simultaneous quantitation of urinary S-phenylmercapturic acid (S-PMA) and trans,trans-muconic acid (t,t-MA). The assay involves spiking urine samples with [13C6]S-PMA and [13C6]t,t-MA as internal standards and clean up of samples by solid-phase extraction with subsequent analysis by liquid chromatography coupled with electrospray-tandem mass spectrometry-selected reaction monitoring (LC-ES-MS/MS-SRM) in the negative ionization mode. The efficacy of this assay was evaluated in human urine specimens from smokers and non-smokers as the benzene-exposed and non-exposed groups. The coefficient of variation of runs on different days (n = 8) for S-PMA was 7% for the sample containing 9.4 microg S-PMA/l urine, that for t,t-MA was 10% for samples containing 0.07 mg t,t-MA/l urine. The mean levels of urinary S-PMA and t,t-MA in smokers were 1.9-fold (P = 0.02) and 2.1-fold (P = 0.03) higher than those in non-smokers. The mean urinary concentration (+/-SE) was 9.1 +/- 1.7 microg S-PMA/g creatinine [median 5.8 microg/g, ranging from not detectable (1 out of 28) to 33.4 microg/g] among smokers. In non-smokers' urine the mean concentration was 4.8 +/- 1.1 microg S-PMA/g creatinine (median 3.6 microg/g, ranging from 1.0 to 19.6 microg/g). For t,t-MA in smokers' urine the mean (+/-SE) was 0.15 +/- 0.03 mg/g creatinine (median 0.11 mg/ g, ranging from 0.005 to 0.34 mg/g); the corresponding mean value for t,t-MA concentration in non-smokers' urine was 0.07 +/- 0.02 mg/g creatinine [median 0.03 mg/g, ranging from undetectable (1 out of 18) to 0.48 mg/g]. There was a correlation between S-PMA and t,t-MA after logarithmic transformation (r = 0.41, P = 0.005, n = 46).
为了研究不同暴露水平如何影响人体中苯的代谢激活途径,并检验尿代谢物与其他生物标志物之间的关系,我们开发了一种灵敏且特异的液相色谱 - 串联质谱分析法,用于同时定量测定尿中S - 苯基巯基尿酸(S - PMA)和反,反 - 粘康酸(t,t - MA)。该分析方法包括在尿样中加入[13C6]S - PMA和[13C6]t,t - MA作为内标,通过固相萃取对样品进行净化,随后采用液相色谱与电喷雾 - 串联质谱 - 选择反应监测(LC - ES - MS/MS - SRM)在负离子模式下进行分析。在来自吸烟者和非吸烟者的人体尿样(分别作为苯暴露组和非暴露组)中评估了该分析方法的效能。对于含9.4μg S - PMA/L尿的样品,不同日期(n = 8)测定S - PMA的变异系数为7%;对于含0.07mg t,t - MA/L尿的样品,测定t,t - MA的变异系数为10%。吸烟者尿中S - PMA和t,t - MA的平均水平分别比非吸烟者高1.9倍(P = 0.02)和2.1倍(P = 0.03)。吸烟者尿中S - PMA的平均浓度(±SE)为9.1±1.7μg S - PMA/g肌酐[中位数5.8μg/g,范围从不可检测(28份中有1份)到33.4μg/g]。在非吸烟者尿中,平均浓度为4.8±1.1μg S - PMA/g肌酐(中位数3.6μg/g,范围从1.0到19.6μg/g)。对于吸烟者尿中的t,t - MA,平均(±SE)为0.15±0.03mg/g肌酐(中位数0.11mg/g,范围从0.005到0.34mg/g);非吸烟者尿中t,t - MA浓度的相应平均值为0.07±0.02mg/g肌酐[中位数0.03mg/g,范围从不可检测(18份中有1份)到0.48mg/g]。经对数转换后,S - PMA与t,t - MA之间存在相关性(r = 0.41,P = 0.005,n = 46)。